Stockreport

FDA Approves New Sleep Drug With Claims Of Less Risk Of Unpleasant Side Effects [Forbes]

EISAI CO S/ADR  (ESALY) 
NASDAQ:AMEX Investor Relations: eisai.com/ir/index.html
PDF For those who suffer from insomnia, the answer is not simple. Of the few medications on the market, many cause a slew of unpleasant and sometimes dangerous side effects. [Read more]